Sax Wealth Advisors LLC increased its holdings in JPMorgan International Research Enhanced Equity ETF (NYSEARCA:JIRE – Free Report) by 16.5% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 409,691 shares of the company’s stock after purchasing an additional 58,008 shares during the period. JPMorgan International Research Enhanced Equity ETF makes up 1.0% of Sax Wealth Advisors LLC’s portfolio, making the stock its 20th biggest position. Sax Wealth Advisors LLC’s holdings in JPMorgan International Research Enhanced Equity ETF were worth $33,660,000 as of its most recent SEC filing.
Several other large investors also recently modified their holdings of JIRE. Cedar Mountain Advisors LLC raised its stake in JPMorgan International Research Enhanced Equity ETF by 3.5% during the first quarter. Cedar Mountain Advisors LLC now owns 4,163 shares of the company’s stock worth $315,000 after acquiring an additional 142 shares in the last quarter. Arete Wealth Advisors LLC raised its stake in shares of JPMorgan International Research Enhanced Equity ETF by 2.5% in the first quarter. Arete Wealth Advisors LLC now owns 10,015 shares of the company’s stock valued at $759,000 after acquiring an additional 244 shares during the last quarter. GoalVest Advisory LLC boosted its stake in JPMorgan International Research Enhanced Equity ETF by 51.1% in the second quarter. GoalVest Advisory LLC now owns 822 shares of the company’s stock worth $68,000 after purchasing an additional 278 shares in the last quarter. Ruggaard & Associates LLC lifted its position in JPMorgan International Research Enhanced Equity ETF by 2.5% during the 4th quarter. Ruggaard & Associates LLC now owns 14,152 shares of the company’s stock worth $1,060,000 after buying an additional 348 shares in the last quarter. Finally, Aegis Wealth Management Inc. raised its stake in shares of JPMorgan International Research Enhanced Equity ETF by 8.3% in the first quarter. Aegis Wealth Management Inc. now owns 4,935 shares of the company’s stock worth $374,000 after acquiring an additional 377 shares during the last quarter.
JPMorgan International Research Enhanced Equity ETF Price Performance
Shares of JIRE stock traded up $0.09 during trading hours on Tuesday, reaching $81.70. 99,459 shares of the company were exchanged, compared to its average volume of 485,559. The company has a market cap of $10.94 billion, a price-to-earnings ratio of 16.04 and a beta of 0.78. The stock’s fifty day moving average is $83.94 and its two-hundred day moving average is $81.72. JPMorgan International Research Enhanced Equity ETF has a fifty-two week low of $71.85 and a fifty-two week high of $86.07.
JPMorgan International Research Enhanced Equity ETF Profile
The JPMorgan International Research Enhanced Equity ETF (JIRE) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively managed ETF that provides exposure to stocks of any market capitalization from developed markets, excluding North America. JIRE was launched on Jun 10, 2022 and is managed by JPMorgan Chase.
Featured Articles
- Five stocks we like better than JPMorgan International Research Enhanced Equity ETF
- Surgical Precision, Sustainable Returns: Johnson & Johnson Secures its Cash Flow Runway
- Tesla’s Robotaxi Lands in Paris—But Europe’s Real Fight Is Over Cheap EVs
- IonQ Fell 9% on a $1.3 Billion Deal—Is Wall Street Missing Something?
- JPMorgan Earnings Miss Estimates But Reveal Broad-Based Strength
Want to see what other hedge funds are holding JIRE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for JPMorgan International Research Enhanced Equity ETF (NYSEARCA:JIRE – Free Report).
Receive News & Ratings for JPMorgan International Research Enhanced Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JPMorgan International Research Enhanced Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.
